Related Experiment Video
Updated: Mar 10, 2026
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Management of necrotizing scleritis after pterygium surgery with rituximab
Tania Sales de Alencar Fidelix1, Luis Antonio Vieira1, Virginia Fernandes Moca Trevisani1
1Departamento de Oftalmologia e Ciências Visuais, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
The authors present a case of necrotizing scleritis after pterygium excision successfully treated with rituximab after attempts with high doses of corticosteroids and immunosuppressive drugs. A literature review revealed case reports and a phase I/II dose-ranging randomized clinical trial using rituximab for necrotizing scleritis with or without association with autoimmune disease. This is the only case report on rituximab treatment for necrotizing scleritis after pterygium surgery. In cases with refractoriness to immunosuppressive drugs, a CD20 antibody can be used.
The authors present a case of necrotizing scleritis after pterygium excision successfully treated with rituximab after attempts with high doses of corticosteroids and immunosuppressive drugs. A literature review revealed case reports and a phase I/II dose-ranging randomized clinical trial using rituximab for necrotizing scleritis with or without association with autoimmune disease. This is the only case report on rituximab treatment for necrotizing scleritis after pterygium surgery. In cases with refractoriness to immunosuppressive drugs, a CD20 antibody can be used.
